Scopus
YÖKSİS DOI Eşleşti
SJR Q2
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
Internal Medicine Journal · Ekim 2018
Özet
Background: Procalcitonin (PCT) and C-reactive protein (CRP) are used most widely in the diagnosis/treatment of bacterial infections. These are not infection-specific and may also show increases in other inflammation-causing cases. Aim: To establish a new cut-off value for PCT and CRP to eliminate confusion in the diagnosis and treatment of bacterial infections in haemodialysis (HD) patients. Methods: A total of 1110 patients, 802 with undocumented infection and 308 with documented infection, was included in the study. Results: A total of 802 patients with undocumented infection had a mean CRP value of 12.2 ± 9.6 mg/dL and a mean PCT value of 0.51 ± 0.96 ng/mL and the 308 patients with documented infection had a mean CRP value of 125.9 ± 83.3 mg/dL and a mean PCT value of 13.9 ± 26.9 ng/mL at the time of admittance. In HD patients, the cut-off values for CRP was determined as 19.15 mg/dL and for PCT as 0.685 ng/mL in the presence of infection. The use of these two parameters in combination (CRP ≥19.15 mg/dL and PCT ≥ 0.685 ng/mL) was found to have 95% positive predictive value (PPV) and 93% negative predictive value (NPV) for the diagnosis of infectious diseases in HD patients. When CRP ≥100 mg/dL and PCT ≥5 ng/mL, this was found to have 100% PPV and 94% NPV for the diagnosis of sepsis in HD patients. Conclusion: We specified PCT and CRP cut-off values with high PPV and NPV for revealing the presence of bacterial infection and sepsis in HD patients.
YÖKSİS Kayıtları
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
INTERNAL MEDICINE JOURNAL · 2018 SCI
Prof. Dr. ONUR URAL →
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?.
INTERNAL MEDICINE · 2018 SCI
Prof. Dr. ŞUA SÜMER →
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
Internal Medicine Journal · 2018 SCI
Prof. Dr. ONUR URAL →
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
INTERNAL MEDICINE JOURNAL · 2018 SCI
Prof. Dr. NAZLIM AKTUĞ DEMİR →
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
INTERNAL MEDICINE JOURNAL · 2018 SCI
Prof. Dr. GÜLPERİ ÇELİK →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 2 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 2 kaydı bulundu.
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
2018 ISSN: 1444-0903 SCI
Prof. Dr. ONUR URAL →
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
2018 ISSN: 1444-0903 SCI
Prof. Dr. ONUR URAL →
Makale Bilgileri
Toplam Atıf
15 atıf
· Scopus
ISSN14440903
Yayın TarihiEkim 2018
Cilt / Sayfa48 · 1222-1228
Scopus ID2-s2.0-85054338529
Kurumlar
Necmettin Erbakan Üniversitesi
Meram Turkey
Selçuk Tip Fakültesi
Konya Turkey
Süleyman Demirel University, Faculty of Medicine
Isparta Turkey
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 15.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Internal Medicine Journal
Q2
SJR Skoru0,537
H-Index88
YayıncıJohn Wiley and Sons Inc
ÜlkeUnited States
Internal Medicine (Q2)
Metrikler
15
Atıf